{"title":"Historical aspects of anticholinergic treatment of obstructive airways disease.","authors":"C W Hertz","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"105-9"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11582381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bronchial carcinoma. II. Quantitative measurements of the quality of survival. A prospective randomized study of the result of therapy in inoperable patients with advanced disease.","authors":"E Nõu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Forty-eight bronchial carcinoma patients in clinicoanatomical stage 4 of the disease (advanced disease) were randomly assigned to groups for radiotherapy, chemotherapy (cyclophosphamide) and placebo treatment, respectively. The results were assessed by the survival time and quality of survival. The median survival time was 4.7 months for radiotherapy, 4.7 months for cyclophosphamide and 1.7 months for placebo. The median total sum of vitagram points was 28.1 for radiotherapy, 20.7 for cyclophosphamide and 6.8 for placebo. When calculated per month, the median sum of vitagram points was 5.9 for radiotherapy, 5.7 for cyclophosphamide and 4.8 for placebo. Statistically the results give no reason to believe that placebo is better than radiotherapy, but it cannot be excluded that radiotherapy patients could have a much longer survival. As for cyclophosphamide versus radiotherapy, the differences are to uncertain for any conclusion to be drawn.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"104 ","pages":"83-106"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11502969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bronchial mucus in obstructive lung disease.","authors":"M T Lopez-Vidriero","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"33-7"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11512596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SCH 1000 in psychogenic asthma.","authors":"A S Rebuck, H I Marcus","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effects of a beta 2-sympathomimetic (salbutamol or fenoterol) and the anticholinergic SCH 1000 administered both in combination and with placebo were compared in a double-blind random crossover design. Thirty-three patients with atopic, non-atopic and psychogenic asthma were studied. After inhalation of the sympathomimetic in combination with SCH 1000 or placebo the increase in FEV1 was significantly better for three hours (p less than 0.05) than after inhalation of SCH 1000 alone. There was no difference in the response to SCH 1000 in the atopic or non-atopic groups. However, in patients with a major psychogenic component to their asthma the FEV1 response to SCH 1000 was significantly better (p less than 0.05) than in other asthmatics from four to seven hours past inhalation. These findings suggest that SCH 1000 might be a valuable therapeutic agent in patients with psychogenic asthma.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"186-91"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparison of ipratropium bromide and an oral anticholinergic drug in chronic bronchitis.","authors":"A J Otto","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"151-3"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Combined effect of an anticholinergic drug ipratropium bromide and disodium cromoglycate in exercise induced asthma.","authors":"F V Rasmussen, L Madsen, A Bundgaard","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"159-62"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Circadian rhythmicity in medicine with special regard to asthmatic patients.","authors":"K Retiene","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"55-61"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11434448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}